Smoking-Cessation and Stimulant Treatment (S-CAST)
Public ClinicalTrials.gov record NCT01077024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the impact of substance-abuse treatment as usual plus smoking-cessation treatment (TAU+SCT), relative to substance-abuse treatment as usual (TAU), on drug-abuse outcomes. Specifically, this study will evaluate whether concurrent smoking-cessation treatment improves, worsens, or has no effect on stimulant-use outcomes in smokers who are in outpatient substance-abuse treatment for cocaine or methamphetamine dependence.
Study identification
- NCT ID
- NCT01077024
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 538 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2010 (Type not available)
- Primary completion
- Aug 2012 (Actual)
- Completion
- Aug 2012 (Actual)
- Last update posted
- Sep 29, 2021
2010 – 2012
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| La Frontera | Tucson | Arizona | 85713 | — |
| Matrix Institute on Addictions | Rancho Cucamonga | California | 91730 | — |
| Tarzana Treatment Centers | Tarzana | California | 91356 | — |
| Gateway | Jacksonville | Florida | 32246 | — |
| Gibson Recovery Center, Inc. | Cape Girardeau | Missouri | 63703 | — |
| Maryhaven | Columbus | Ohio | 43207 | — |
| ADAPT | Roseburg | Oregon | 97470 | — |
| Addiction Medicine Services | Pittsburgh | Pennsylvania | 15213 | — |
| Lexington/Richland Alcohol and Drug Abuse Council | Columbia | South Carolina | 29204 | — |
| Behavioral Health Services of Pickens County | Pickens | South Carolina | 29671 | — |
| Dorchester | Summerville | South Carolina | 29483 | — |
| Nexus Recovery Center | Dallas | Texas | 75228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01077024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2021 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01077024 live on ClinicalTrials.gov.